LifeStance Health (LFST) Gross Profit (2020 - 2024)

LifeStance Health (LFST) has 5 years of Gross Profit data on file, last reported at $100.4 million in Q3 2024.

• Gross Profit for Q3 2024 came in at $100.4 million, up 31.78% year-over-year; the trailing twelve-month figure through Sep 2024 was $376.3 million (up 33.68% YoY), and the FY2023 annual result was $302.1 million, up 27.46% from the prior year.
• Gross Profit advanced to $100.4 million in Q3 2024 per LFST's latest filing, from $97.8 million in the prior quarter.
• Over five years, Gross Profit peaked at $100.4 million in Q3 2024 and troughed at $14.2 million in Q2 2020.
• A 5-year average of $63.6 million and a median of $60.3 million in 2022 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2021 and 2022: Gross Profit jumped 261.18% in 2021, then increased 15.56% in 2022.
• A 5-year view of Gross Profit shows it stood at $33.1 million in 2020, then soared by 63.72% to $54.2 million in 2021, then advanced by 15.56% to $62.7 million in 2022, then surged by 32.89% to $83.3 million in 2023, then gained by 20.55% to $100.4 million in 2024.
• Business Quant data shows LFST's Gross Profit at $100.4 million in Q3 2024, $97.8 million in Q2 2024, and $94.7 million in Q1 2024.